Multinational retail corporation Walmart has partnered with social-impact education innovator EVERFI to launch a new website.
Named as Safe & Well, the new website is an interactive learning solution that provides users with access to prescription drug safety and mental health resources.
Safe & Well leverages videos, interactive scenarios and self-guided activities. It is free for everyone and mobile-friendly.
Some topics include providing information on how to read and understand a prescription bottle label and medication guide, usage, storage and disposal of prescription medication responsibly and identifying opioid misuse and opioid use disorder.
Additionally, the website offers mental health awareness and strategies to help get support for a mental health challenge.
Walmart chief medical officer Dr Thomas Van Gilder said: “We are seeing people struggle with unprecedented levels of personal stress and restricted access to support networks in communities across the country as a result of the pandemic, which can ultimately compromise health and many other important aspects of people’s lives.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData“Our hope is that the new Safe & Well tool will be an accessible and valuable source of information for people at risk of prescription drug misuse and those who care about them.”
The new resource will provide accurate information to users such as associates, patients, caregivers and community members.
It will help gain knowledge on prescription medication misuse risks and links to mental health.
Last month, Walmart reportedly planned to invest up to $25bn in Tata Group’s super app, expected for launch in India in December or January.